Fonte: Bone Marrow Transplantation. Nome do evento: Annual Meeting of the European Group for Blood and Marrow Transplantation. Unidade: FMRP
Assuntos: POLIMORFISMO, TRANSPLANTE DE MEDULA ÓSSEA
ABNT
ROCHA, V. et al. Association of pharmacogenes polymorphisms with toxicities and GvHD after HLA identical sibling bone marrow transplantation. Bone Marrow Transplantation. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 27 set. 2024. , 2004APA
Rocha, V., Porcher, R., Filion, A., Bittencourt, H., Zanette, D., Vilela, G., et al. (2004). Association of pharmacogenes polymorphisms with toxicities and GvHD after HLA identical sibling bone marrow transplantation. Bone Marrow Transplantation. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Rocha V, Porcher R, Filion A, Bittencourt H, Zanette D, Vilela G, Silva Júnior WA da, Devergie A, Esperou H, Ribaud P, Socie G, Gluckman E, Zago MA. Association of pharmacogenes polymorphisms with toxicities and GvHD after HLA identical sibling bone marrow transplantation. Bone Marrow Transplantation. 2004 ; 33 S44.[citado 2024 set. 27 ]Vancouver
Rocha V, Porcher R, Filion A, Bittencourt H, Zanette D, Vilela G, Silva Júnior WA da, Devergie A, Esperou H, Ribaud P, Socie G, Gluckman E, Zago MA. Association of pharmacogenes polymorphisms with toxicities and GvHD after HLA identical sibling bone marrow transplantation. Bone Marrow Transplantation. 2004 ; 33 S44.[citado 2024 set. 27 ]